Jordan Park

Kazia Therapeutics Updates Clinical Progress for Paxalisib in Advanced Triple-Negative Breast Cancer

Promising early results in metastatic TNBC patients as enrollment and site expansion continue

Kazia Therapeutics Ltd. provided a clinical update on its ongoing Phase 1b trial investigating paxalisib in combination with pembrolizumab and chemoth...

Genenta Science Shifts Focus from Biotech to Defense Sector with Strategic Acquisition Plan

Company Sets Sights on Becoming Leading Industrial Consolidator in National Security Markets

Genenta Science S.p.A. is undertaking a significant strategic transformation, moving away from its prior focus on cell therapy development toward beco...

Amazon Reshapes Its Physical Grocery Footprint, Phasing Out Fresh and Go Stores

Strategic Shift Focuses on Expanding Whole Foods Market Presence While Experimenting with Retail Innovations

Amazon has announced the closure of approximately 70 Amazon Fresh and Amazon Go grocery stores across the United States as it refines its physical ret...

Buy the Balance Sheet, Not the Bet - Tactical Apple (AAPL) Long With Guardrails

Valuation looks compelling on cash flow and buybacks; I remain skeptical about the companys newest product technology direction.

Apple looks like a structurally safe name to own from a corporate-finance standpoint - roughly $3.9T market cap, strong operating cash flow and contin...

Analysts Raise Price Targets Following CoreWeave and NVIDIA Partnership Expansion

CoreWeave's Strategic Collaboration with NVIDIA Spurs Investor Confidence Amid Ambitious AI Factory Plans

CoreWeave, Inc. has fortified its alliance with NVIDIA Corporation through a significant investment and a collaborative initiative aimed at deploying ...

Spain Advances Legal Recognition for Undocumented Immigrants

Government Expedites Residency and Work Permits for Hundreds of Thousands Amid Political Debate

Spain's government has announced an expedited plan to grant legal residency and work permits to potentially up to 800,000 immigrants living without au...

Starbucks Faces Earnings Headwinds Amid Strategic Investments in Customer Experience

Fiscal Q1 2026 Will Reveal If Operational Enhancements At 'Green Apron Service' Boost Profits or Exert Margin Pressure

Starbucks is poised to release its first-quarter fiscal 2026 earnings amidst heightened scrutiny of CEO Brian Niccol’s customer-centric 'Back to Sta...

Fitz-Gerald Group Sees Major Product Innovation from Apple This Spring, Highlights Strong AI Positioning

Apple’s Upcoming Launch Expected to Transform Device Design, Reminiscent of iPhone Revolution, Says Fitz-Gerald CIO

Keith Fitz-Gerald, Chief Investment Officer of Fitz-Gerald Group, expressed strong confidence in Apple's upcoming product reveal, anticipated to be a ...

CRISPR Therapeutics Faces Investor Challenges Amid Insider Stock Sales and Revenue Shortfalls

Stock Momentum Declines as CEO Share Disposals and Underwhelming Financial Results Raise Concerns

CRISPR Therapeutics AG, a leading player in biotechnology and a mainstay in Cathie Wood’s Ark Invest portfolios, is encountering downward pressure i...

Fulgent Genetics - Price Has Rallied; Fundamentals Still Support a Tactical Long

Cash-rich lab operations, steady revenue run-rate and a cheap market cap-to-book — buy on weakness with defined risk controls.

Fulgent Genetics (FLGT) has re-priced higher after a deep selloff in 2024-2025. The business is now trading roughly in-line with a healthier fundament...